AKT1 and ovarian cancer: Furthermore, the Akt signaling pathway may mediate miR-93-induced chemoresistance to cisplatin in A2780 cells, providing a novel approach to the study of drug resistance and may contribute to discovering new therapies curing ovarian cancer [35].